AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Challenge Grants
This grant funds innovative research to improve detection, diagnosis, treatment, and prevention of invasive lobular carcinoma, a common breast cancer subtype.
Funder: American Association for Cancer Research
Due Dates: September 10, 2026 (Full application, 1:00 p.m. U.S. Eastern Time)
Funding Amounts: $50,000 for a one-year project; direct and indirect costs included (max 5% indirect).
Summary: Supports innovative research advancing detection, diagnosis, treatment, and recurrence prevention for invasive lobular carcinoma (ILC) of the breast.
Key Information: Applicants must be AACR Active members in good standing by the deadline; open globally.
Description
This funding opportunity aims to stimulate creative, paradigm-shifting research in invasive lobular carcinoma (ILC), the second most common histological subtype of breast cancer. Grants support projects that advance detection, diagnosis, pathology, treatment, recurrence prevention, or surveillance of ILC. Both established ILC researchers and investigators from other cancer or biomedical fields are encouraged to apply. The program is designed to fund innovative ideas that may not be supported through conventional channels, with the goal of improving patient outcomes and understanding of lobular breast cancer.
